Mutations in the tyrosine kinase domain of epidermal growth factor receptor 1 (EGFR) occur in ~10–40% non-small cell lung cancers (NSCLC), with the highest incidence in patients of Asian descent [13–16]. Here, EGFR is linked to non-small cell lung carcinoma.